Scientists are testing whether GLP-1 drugs can help to cut cravings for cigarettes, alcohol and opioids — as well as food.

GLP-1 (glucagon-like peptide) class diabetes and obesity treatments such as ‘Wegovy’ and ‘Mounjaro’ are generating sequential ...

Research clinical data showing that obesity treatments like ‘Wegovy’ and ‘Mounjaro’ can also aid in treating alcohol, tobacco ...

Studies show promising results for semaglutide as a potential treatment for alcohol use disorder. Semaglutide, a GLP-1 drug, was initially used for type 2 diabetes treatment and weight loss. While ...

Scientists have long known that psychedelics like LSD can help the brain grow new connections. These drugs promote something called neuroplasticity, which helps the brain heal from mental illness. But ...

A study using Swedish patient data found anti-obesity drugs were linked with fewer hospitalizations related to alcohol use, adding to a body of work suggesting these drugs could potentially be used to ...

The U.S. Food and Drug Administration set forth new guidance for research on psychedelics like LSD or psilocybin and other drugs like ketamine or MDMA for the treatment of post-traumatic stress ...

LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the U.S. for ...

This article was featured in One Story to Read Today, a newsletter in which our editors recommend a single must-read from The Atlantic, Monday through Friday. Sign up for it here. In Louisville, ...

A US study of more than a million Medicaid enrollees newly diagnosed with opioid use disorder (OUD), finds most—nearly seven ...